Healthcare - Biotechnology - NASDAQ - US
$ 1.77
-8.29 %
$ 78.9 M
Market Cap
-1.16
P/E
Price Target
Average
577.97%
Revenue Forecast
Estimate
38.36%
EBIT
Estimate
23.96%
Net Income
Estimate
--12.89%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Werewolf Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for HOWL of $12 , with forecasts ranging from a low of $12 to a high of $12 .
HOWL Lowest Price Target
Wall Street Target
12 USD
577.97%
HOWL Average Price Target
Wall Street Target
12 USD
577.97%
HOWL Highest Price Target
Wall Street Target
12 USD
577.97%
REVENUE FORECAST
Revenue Forecast Chart HOWL
EBIT FORECAST
EBIT Forecast Chart HOWL
NET INCOME FORECAST
Net Income Chart HOWL